Ionis Pharmaceuticals (IONS) Tmuɣli n wazal
Ṛṛbem n lḥedd$44.49Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel+1.55%
Asnulfu n AI: IONS
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Ionis Pharmaceuticals, Inc. is a biopharmaceutical company that conducts research to identify and develop RNA-targeted therapeutics. Ionis Pharmaceuticals serves customers in the United States.
